<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Clinical utility gene card for: Hereditary thoracic aortic aneurysm and dissection including next-generation sequencing-based approaches</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-10-28">28 October 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>Dr</roleName><forename type="first">Mine</forename><surname>Arslan-Kirchner</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Institute of Human Genetics</orgName>
								<orgName type="department" key="dep2">Hannover Medical School</orgName>
								<address>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Eloisa</forename><surname>Arbustini</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">IRCCS Fondazione Policlinico San Matteo</orgName>
								<address>
									<settlement>Pavia</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Catherine</forename><surname>Boileau</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Medical Genetics</orgName>
								<orgName type="institution" key="instit1">Bichat University Hospital</orgName>
								<orgName type="institution" key="instit2">APHP</orgName>
								<address>
									<settlement>Paris</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Philippe</forename><surname>Charron</surname></persName>
							<affiliation key="aff3">
								<orgName type="laboratory">Centre de Référence Maladies Cardiaques Héréditaires</orgName>
								<orgName type="institution" key="instit1">Université de Versailles-Saint Quentin</orgName>
								<orgName type="institution" key="instit2">Hôpital Ambroise Paré</orgName>
								<orgName type="institution" key="instit3">APHP</orgName>
								<address>
									<settlement>Boulogne-Billancourt</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anne</forename><forename type="middle">H</forename><surname>Child</surname></persName>
							<affiliation key="aff4">
								<orgName type="institution" key="instit1">Cardiovascular and Cell Sciences Research Institute</orgName>
								<orgName type="institution" key="instit2">St George&apos;s University of London</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gwenaelle</forename><surname>Collod-Beroud</surname></persName>
							<affiliation key="aff5">
								<orgName type="institution" key="instit1">Aix Marseille Université</orgName>
								<orgName type="institution" key="instit2">INSERM</orgName>
								<orgName type="institution" key="instit3">GMGF UMR_S 910</orgName>
								<address>
									<settlement>Marseille</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Julie</forename><surname>De Backer</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Center for Medical Genetics</orgName>
								<orgName type="institution">Ghent University</orgName>
								<address>
									<settlement>Ghent</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anne</forename><surname>De Paepe</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Center for Medical Genetics</orgName>
								<orgName type="institution">Ghent University</orgName>
								<address>
									<settlement>Ghent</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anna</forename><surname>Dierking</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Institute of Human Genetics</orgName>
								<orgName type="department" key="dep2">Hannover Medical School</orgName>
								<address>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Laurence</forename><surname>Faivre</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Centre de Génétique</orgName>
								<orgName type="institution">Centre Hospitalier Universitaire de Dijon</orgName>
								<address>
									<settlement>Dijon</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sabine</forename><surname>Hoffjan</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Department of Human Genetics</orgName>
								<orgName type="institution">Ruhr University Bochum</orgName>
								<address>
									<settlement>Bochum</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Guillaume</forename><surname>Jondeau</surname></persName>
							<affiliation key="aff9">
								<orgName type="institution" key="instit1">Centre National de Référence Pour le Syndrome de Marfan et Apparentés</orgName>
								<orgName type="institution" key="instit2">CHU Hôpital Xavier Bichat-Claude Bernard</orgName>
								<address>
									<settlement>Paris</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Britta</forename><surname>Keyser</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Institute of Human Genetics</orgName>
								<orgName type="department" key="dep2">Hannover Medical School</orgName>
								<address>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bart</forename><surname>Loeys</surname></persName>
							<affiliation key="aff10">
								<orgName type="department">Center for Medical Genetics</orgName>
								<orgName type="institution" key="instit1">University of Antwerp</orgName>
								<orgName type="institution" key="instit2">Antwerp University Hospital</orgName>
								<address>
									<settlement>Antwerp</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Karin</forename><surname>Mayer</surname></persName>
							<affiliation key="aff11">
								<orgName type="laboratory">Center for Human Genetics and Laboratory Diagnostics (AHC)</orgName>
								<address>
									<settlement>Martinsried</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><forename type="middle">N</forename><surname>Robinson</surname></persName>
							<affiliation key="aff12">
								<orgName type="department">Institut für Medizinische Genetik und Humangenetik</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jörg</forename><surname>Schmidtke</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Institute of Human Genetics</orgName>
								<orgName type="department" key="dep2">Hannover Medical School</orgName>
								<address>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff13">
								<orgName type="department" key="dep1">Institute of Human Genetics</orgName>
								<orgName type="department" key="dep2">Hannover Medical School</orgName>
								<address>
									<addrLine>Carl-Neuberg-Straße 1</addrLine>
									<postCode>30625</postCode>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Clinical utility gene card for: Hereditary thoracic aortic aneurysm and dissection including next-generation sequencing-based approaches</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-10-28">28 October 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">7A53E98887E9D0AF256A4052AD1D0D3B</idno>
					<idno type="DOI">10.1038/ejhg.2015.225</idno>
					<note type="submission">Received 22 April 2015; revised 28 July 2015; accepted 30 July 2015;</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:27+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>This CUGC intends to give guidance regarding molecular genetic testing in patients with thoracic aortic aneurysm and dissection (for definition see Loeys et al. <ref type="bibr" target="#b0">1</ref> ).</s><s>It includes genes associated with nonsyndromic and syndromic conditions.</s><s>In cases of a strong clinical suspicion for a particular syndrome, it recommends testing the respective associated genes first.</s><s>In cases without such suspicion, it recommends either a stepwise approach by Sanger sequencing or, if available, NGS-based procedures according to the ESHG recommendations (Matthijs et al. <ref type="bibr" target="#b1">2</ref> ) based on 'core genes' and 'additional genes'.</s><s>The recommendations suggest that core gene lists are to be established by consensus among experts in the field.</s><s>The 'list must result in a 'substantial contribution' to the quality of life of a patient, and hence the genes must be chosen with care; a two tier system would be acceptable, whereby some genes are scrutinized more in detail (in other words: with a more complete coverage) than others; the list must not inflict with the efficiency of a service, that is, overzealous testing is not helpful; the use of core gene panels must lead to better diagnosis of the group of disorders, if not it lacks clinical utility.' <ref type="bibr" target="#b1">2</ref> Additional genes (those with a lower disease contribution) are optional components of the panel.</s><s>1.4 Mutational spectrum:</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">DISEASE CHARACTERISTICS</head><p><s>(Please note the EJHG instructions for authors http://mts-ejhg.nature.</s><s>com/cgi-bin/main.plex?form_type=display_auth_instructions regarding sequence variants and genetic databases.)</s><s>All types of variants have been reported 3 (missense, nonsense, splice site, small and large deletions/insertions).</s><s>Many variants are listed in the Human Gene Mutation Database (http://www.hgmd.org/)</s><s>and in ClinVar. <ref type="bibr" target="#b3">4</ref> The 'Locus Specific Mutation Database' from HGVS gives an overview of gene-specific mutation databases, for example, FBN1, FBN2, TGFBR1, TGFBR2, ACTA2, SMAD3, MYH11 and MYLK variants are also registered in The Universal Mutation Database (www.umd.be).</s><s>In general, there are no frequent disease-causing mutations or hot spots for disease-causing mutations in the vast majority of the genes.</s><s>Causative mutations are distributed throughout the genes.</s><s>However, some trends are observed for disease-causing mutations in specific genes (for example, exons encoding intracellular domains of TGFBR1 and TGFBR2, and recurrent mutations in PRKG1).</s></p><p><s>SNPs or rare variants are listed in the dbSNP Database (http://www.</s><s>ncbi.nlm.nih.gov/snp/), the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/)</s><s>and in the Exome Aggregation Consortium (http://exac.broadinstitute.org/).</s><s>Please note that the above-mentioned databases include pathogenic mutations.</s><s>Note: the nomenclature of diseases associated with thoracic aortic aneurysm is in part controversial. <ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b15">16</ref></s><s>This CUGC does not attempt to resolve these controversies.</s><s>In this table, both OMIM and Orpha numbers are given together with their alternative disease designations in the first column.</s><s>a ATS is used in OMIM as a symbol for both conditions.</s><s>If known to be variable between ethnic groups, please report): Estimated population prevalence ranges between 1:5000 and 1:4 000 000 in adults depending on the occurrence of an isolated thoracic aortic aneurysm or as a symptom of a syndromic disorder, excluding non-genetic causes, for example, atherosclerosis.</s><s>2.1 Analytical sensitivity (proportion of positive tests if the genotype is present in the analyte)</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.5">Analytical validation</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">TEST CHARACTERISTICS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1.1">if tested by conventional Sanger sequencing</head><p><s>Less than 100%.</s><s>The proportion is likely o100%, because primers may be localized on sequences containing SNPs or rare variants, which results in a preferential amplification of one allele (allele drop out).</s><s>A supplementary deletion/duplication diagnostic test should be performed for genes with a known proportion of large genomic deletions/ duplications.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1.2">if tested by next-generation sequencing</head><p><s>Less than 100%.</s></p><p><s>The proportion is likely o100%, because there might be diseasecausing mutations in regions that could not be enriched and/or sequenced by NGS due to suboptimal coverage of some regions of interest with this technology but depending on NGS strategy.</s><s>If amplicon-based enrichment strategies are being used, primers may be localized on SNPs or rare variants, which results in a preferential amplification of one allele.</s><s>In patients with a highly suggestive phenotype in whom initial testing for specific gene alterations proves negative, a supplementary deletion/duplication diagnostic test should be performed for genes with a known proportion of large genomic deletions/duplications.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2">Analytical specificity (proportion of negative tests if the genotype is not present)</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.1">if tested by conventional Sanger sequencing</head><p><s>Nearly 100%.</s><s>False positives may at the most arise due to misinterpretation of rare polymorphic variants.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.2">if tested by next-generation sequencing</head><p><s>Less than 100%.</s><s>The risk of false positives due to misinterpretation of rare polymorphic variants may even be higher compared with Sanger sequencing because of the greater number of analysed genes.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3">Clinical sensitivity (proportion of positive tests if the disease is present)</head><p><s>The clinical sensitivity can be dependent on variable factors such as age or family history.</s><s>In such cases, a general statement should be given, even if a quantification can only be made case by case.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.1">if tested by conventional Sanger sequencing</head><p><s>In about 20% of patients presenting with familial AAT, a diseasecausing mutation is found 5 (eg, ACTA2: 4-14%, TGFBR2: 4%, SMAD3: 2%, TGFBR1: 1%, MYH11: 1%, MYLK: 1%, TGFB2, MAT2A, PRKG1, MFAP5).</s></p><p><s>In syndromic forms of heritable thoracic aortic aneurysm clinical sensitivity is highly dependent on fulfillment of specific clinical criteria for a given entity.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.2">if tested by next-generation sequencing</head><p><s>See 2.3.1.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4">Clinical specificity (proportion of negative tests if the disease is not present)</head><p><s>The clinical specificity can be dependent on variable factors such as age or family history.</s><s>In such cases, a general statement should be given, even if a quantification can only be made case by case.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.1">if tested by conventional Sanger sequencing</head><p><s>Unknown.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.2">if tested by Next-generation sequencing</head><p><s>See 2.4.1.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.5">Positive clinical predictive value (life time risk to develop the disease if the test is positive)</head><p><s>Dependent on clinical subtype, typically 450%.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.6">Negative clinical predictive value (Probability not to develop the disease if the test is negative)</head><p><s>Assume an increased risk based on family history for a non-affected person.</s><s>Allelic and locus heterogeneity must need to be considered.</s></p><p><s>Index case in that family had been tested and a causative mutation identified:</s></p><p><s>Nearly 100%.</s><s>If the non-affected relative is not carrier of an identified disease-causing mutation, he or she has no increased risk, except a small risk related to the prevalence of the disease in the general population.</s></p><p><s>Index case in that family had not been tested or no causative mutation identified: Up to 19% of patients with TAAD without a known genetic syndrome have a first-degree relative with TAAD. <ref type="bibr" target="#b5">6</ref></s><s>In syndromic forms of heritable thoracic aortic aneurysm, the negative clinical predictive value corresponds to the detection rate in the known genes mutated in the different diseases. <ref type="bibr" target="#b6">7</ref></s><s> CLINICAL UTILITY 3.1 (Differential) diagnostics: The tested person is clinically affected (To be answered if in 1.8 'A' was marked) Regular vascular examination and determination of the best time for surgery.</s><s><ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b12">13</ref> Depending on the diseasecausing gene, it may be necessary to extend vascular imaging beyond the aorta.</s><s>Furthermore, it is necessary to examine for specific syndromic complications, for example, hollow-organ rupture in Ehlers-Danlos syndrome type IV.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2">Predictive Setting:</head><p><s>The tested person is clinically unaffected but carries an increased risk based on family history (To be answered if in 1.8 'B' was marked)</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.1">Will the result of a genetic test influence lifestyle and prevention?</head><p><s>If the test result is positive (please describe), see 3.1.4.</s></p><p><s>If the test result is negative (please describe), if the causative mutation is identified in the index case and not in the clinically unaffected proband, regular examinations are not necessary unless otherwise indicated.</s></p><p><s>Follow-up is recommended if the disease-causing mutation could not be identified.</s><s>In contrast, follow-up is dispensable in a family member, if a familial mutation has been excluded.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>3.2.2</head><p><s>Which options in view of lifestyle and prevention does a person at-risk have if no genetic test has been done (please describe)?</s><s>That person should avoid sport activity/professional activity with a high static burden, competitive sports and body contact sports.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3">Genetic risk assessment in family members of a diseased person</head><p><s>(To be answered if in 1.8 'C' was marked) 3.3.1 Does the result of a genetic test resolve the genetic situation in that family?</s><s>Yes, if a causative mutation could be identified in the index patient.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3.2">Can a genetic test in the index patient save genetic or other tests in family members?</head><p><s>If a disease-causing mutation is identified in the index patient, family members can be tested (cascade screening).</s><s>Test negative family members can be released from otherwise indicated diagnostic monitoring.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">IF APPLICABLE, FURTHER CONSEQUENCES OF TESTING</head><p><s>Please assume that the result of a genetic test has no immediate medical consequences.</s><s>Is there any evidence that a genetic test is nevertheless useful for the patient or his/her relatives?</s><s>(Please describe).</s></p><p><s>The genetic diagnostics contributes substantially to the classification of a heritable thoracic aortic aneurysm to a syndromic or nonsyndromic entity. <ref type="bibr" target="#b13">14</ref></s><s>Genetic testing gives insight to inheritance pattern and allows reasonable genetic counseling.</s><s>If a causative mutation is identified in a gene also responsible for a syndromic form of TAAD, further clinical investigations regarding symptoms of this specific syndrome should be performed.</s><s>In some cases it might be justified to start medical treatment at an earlier stage.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>3. 3 . 3 3 . 4</head><label>3334</label><figDesc><div><p><s>Does a positive genetic test result in the index patient enable a predictive test in a family member?</s><s>Yes.</s><s>Prenatal diagnosis (To be answered if in 1.8 'D' was marked) 3.4.1 Does a positive genetic test result in the index patient enable a prenatal diagnosis?</s><s>Yes.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head></head><label></label><figDesc><div><p><s>1.1 Name of the disease (synonyms) See Table 1 column 1-'Disease'.</s><s>1.2 OMIM# of the disease See Table 1 column 2-'OMIM# of Disease', and Table 2. 1.3 Name of the analysed genes or DNA/chromosome segments: 1.3.1 Core genes (irrespective if being tested by Sanger sequencing or next-generation sequencing)</s></p></div></figDesc><table><row><cell>Gene</cell><cell></cell><cell cols="3">OMIM# of associated gene(s)</cell></row><row><cell>ACTA2</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>COL3A1</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>FBN1</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>FLNA</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>MAT2A</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>MFAP5</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>MYH11</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>MYLK</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>NOTCH1</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>PRKG1</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>SMAD3</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>TGFB2</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>TGFB3</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>TGFBR1</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>TGFBR2</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="5">1.3.2 Additional genes (if tested by next-generation sequencing,</cell></row><row><cell>including</cell><cell>whole-exome/genome</cell><cell>sequencing</cell><cell>and</cell><cell>panel</cell></row><row><cell>sequencing)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Gene</cell><cell></cell><cell cols="3">OMIM# of associated gene(s)</cell></row><row><cell>COL1A1</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>COL4A5</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>COL5A1</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>COL5A2</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>EFEMP2</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>ELN</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>FBN2</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>GATA5</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>PLOD1</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>SKI</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>SLC2A10</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>SMAD4</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1</head><label>1</label><figDesc><div><p><s>Overview of diseases and genes associated with thoracic aortic aneurysm</s></p></div></figDesc><table><row><cell>Sequencing of both DNA strands. Disease-causing mutations should</cell></row><row><cell>be confirmed using genomic DNA from a new extraction. Causative</cell></row><row><cell>mutations found with next-generation sequencing should be verified</cell></row><row><cell>using Sanger sequencing or other specific molecular methods (eg, PCR</cell></row><row><cell>digest); for further details, see the Eurogentest Guideline. 2</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2</head><label>2</label><figDesc><div><p><s>Genes associated with thoracic aortic aneurysm not yet given an OMIM or Orpha number</s></p></div></figDesc><table><row><cell>Gene</cell><cell>OMIM# of gene</cell></row><row><cell>GATA5 17</cell><cell>611496</cell></row><row><cell>MAT2A 18</cell><cell>601468</cell></row><row><cell>MFAP5 19</cell><cell>601103</cell></row><row><cell>TGFB3 20</cell><cell>190230</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head></head><label></label><figDesc><div><p><s>Comment: panel diagnostic or WES/WGS filtering should be preferred if clinical signs of a specific syndrome are missing, for example, in young patients with an emerging syndrome.</s><s>But also in older persons, a specific syndrome can have a widely variable expression.</s><s>Time constraints, for example, in pregnancy, is another reason to choose panel diagnostic, if there is a request for prenatal diagnosis (rarely) or if the modus of delivery is dependent on a specific condition of the child.</s></p></div></figDesc><table><row><cell>1.7 Diagnostic setting:</cell><cell></cell><cell></cell></row><row><cell></cell><cell>Yes</cell><cell>No</cell></row><row><cell>A. (Differential) diagnostics</cell><cell>⊠</cell><cell>□</cell></row><row><cell>B. Predictive testing</cell><cell>⊠</cell><cell>□</cell></row><row><cell>C. Risk assessment in relatives</cell><cell>⊠</cell><cell>□</cell></row><row><cell>D. Prenatal</cell><cell>⊠</cell><cell>□</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head></head><label></label><figDesc><div><p><s>3.1.1</s><s>Can a diagnosis be made other than through a genetic test?</s></p></div></figDesc><table><row><cell>No</cell><cell cols="2">□ (continue with 3.1.4)</cell></row><row><cell>Yes</cell><cell>⊠</cell></row><row><cell></cell><cell cols="2">Clinically</cell><cell>⊠</cell></row><row><cell></cell><cell cols="2">Imaging</cell><cell>⊠</cell></row><row><cell></cell><cell cols="2">Endoscopy</cell><cell>□</cell></row><row><cell></cell><cell cols="2">Biochemistry</cell><cell>□</cell></row><row><cell></cell><cell cols="2">Electrophysiology</cell><cell>□</cell></row><row><cell></cell><cell cols="2">Other (please describe)</cell><cell>Slit lamp examination</cell></row><row><cell cols="3">3.1.2 Describe the burden of alternative diagnostic methods to the</cell></row><row><cell>patient</cell><cell></cell></row><row><cell cols="3">A clinically affected person has to be regularly examined by echo-</cell></row><row><cell cols="3">cardiogram, CT or MR imaging. 8</cell></row><row><cell cols="3">Alternative diagnostic methods might not capture early detection of</cell></row><row><cell cols="3">none cardiovascular symptoms in syndromic cases.</cell></row><row><cell cols="3">3.1.3 How is the cost effectiveness of alternative diagnostic methods to</cell></row><row><cell>be judged?</cell><cell></cell></row><row><cell cols="2">No data available.</cell></row><row><cell cols="3">3.1.4 Will disease management be influenced by the result of a</cell></row><row><cell>genetic test?</cell><cell></cell></row><row><cell>No □</cell><cell></cell></row><row><cell>Yes ⊠</cell><cell></cell></row><row><cell cols="2">Therapy (please</cell><cell>Earlier surgical therapy in young patients with disease-</cell></row><row><cell>describe)</cell><cell></cell><cell>causing TGFBR1 and TGFBR2 mutations and clinical</cell></row><row><cell></cell><cell></cell><cell>signs of LDS has been suggested by some authors 9 but</cell></row><row><cell></cell><cell></cell><cell>not others 10</cell></row><row><cell cols="2">Prognosis (please</cell><cell>Prophylactic surgery and pharmacological therapy lead</cell></row><row><cell>describe)</cell><cell></cell><cell>to a better prognosis 11</cell></row><row><cell cols="2">Management (please</cell></row><row><cell>describe)</cell><cell></cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">European Journal of Human Genetics</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGEMENTS</head><p><s>CUGCs were developed within a work package of EuroGentest2 (Unit 2: 'Genetic testing as part of health care'), a Coordination Action under FP7 (Grant Agreement Number 261469).</s><s>Currently, the initiative is supported by the European Society of Human Genetics.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONFLICT OF INTEREST</head><p><s>The authors declare no conflict of interest.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">The revised Ghent nosology for the Marfan syndrome</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Loeys</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Dietz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Braverman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Med Genet</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="476" to="485" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Guidelines for diagnostic next generation sequencing</title>
		<author>
			<persName><forename type="first">G</forename><surname>Matthijs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Souche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Alders</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="2" to="5" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">The spectrum of FBN1, TGFβR1, TGFβR2 and ACTA2 variants in 594 individuals with suspected Marfan Syndrome, Loeys-Dietz Syndrome or Thoracic Aortic Aneurysms and Dissections (TAAD)</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Lerner-Ellis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Aldubayan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Hernandez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Genet Metab</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="171" to="176" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">ClinVar: public archive of relationships among sequence variation and human phenotype</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Landrum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Riley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="D980" to="D985" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Thoracic aortic aneurysms and aortic dissections</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Milewicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Regalado</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gene Reviews</title>
		<editor>Pagon RA, Adam MP, Ardinger HH</editor>
		<imprint>
			<date type="published" when="1993">1993-2014</date>
		</imprint>
		<respStmt>
			<orgName>University of Washington</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Familial thoracic aortic aneurysms and dissections-incidence, modes of inheritance, and phenotypic patterns</title>
		<author>
			<persName><forename type="first">G</forename><surname>Albornoz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Coady</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Roberts</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Thorac Surg</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="1400" to="1405" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">The Ehlers-Danlos syndrome</title>
		<author>
			<persName><forename type="first">F</forename><surname>Malfait</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>De Paepe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Exp Med Biol</title>
		<imprint>
			<biblScope unit="volume">802</biblScope>
			<biblScope unit="page" from="129" to="143" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">CT angiographic evaluation of genetic vascular disease: role in detection, staging, and management of complex vascular pathologic conditions</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Chu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Dietz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">K</forename><surname>Fishman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AJR Am J Roentgenol</title>
		<imprint>
			<biblScope unit="volume">202</biblScope>
			<biblScope unit="page" from="1120" to="1129" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Hiratzka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Bakris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Beckman</surname></persName>
		</author>
		<ptr target="ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM" />
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="e266" to="e369" />
			<date type="published" when="2010">2010. 2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC)</title>
		<author>
			<persName><forename type="first">R</forename><surname>Erbel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Aboyans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Boileau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="2873" to="2926" />
			<date type="published" when="2014">2014. 2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Survival is affected by mutation type and molecular mechanism in vascular Ehlers-Danlos syndrome (EDS type IV)</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Pepin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Schwarze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Rice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Leistritz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Byers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genet Med</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="881" to="888" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Aortopathies: etiologies, genetics, differential diagnosis, prognosis and management</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Paterick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Humphries</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Ammar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="page" from="670" to="678" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Management of aortic aneurysms in patients with connective tissue disease</title>
		<author>
			<persName><forename type="first">F</forename><surname>Schoenhoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schmidli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Czerny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Carrel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cardiovasc Surg (Torino)</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="125" to="134" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>Suppl 1</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Heritable thoracic aortic disorders</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Pyeritz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Cardiol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="97" to="102" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Loeys-Dietz syndrome is a specific phenotype and not a concomitant of any mutation in a gene involved in TGF-β signaling</title>
		<author>
			<persName><forename type="first">R</forename><surname>Pyeritz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Jondeau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Moran</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genet Med</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="641" to="642" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Response to Pyeritz et al</title>
		<author>
			<persName><forename type="first">G</forename><surname>Maccarrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Loeys</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Dietz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genet Med</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="642" to="644" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Rare non-synonymous variations in the transcriptional activation domains of GATA5 in bicuspid aortic valve disease</title>
		<author>
			<persName><forename type="first">R</forename><surname>Padang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Bagnall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Richmond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Bannon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Semsarian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mol Cell Cardiol</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="277" to="281" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">MAT2A mutations predispose individuals to thoracic aortic aneurysms</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Gong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Regalado</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="170" to="177" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">mfap5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissections</title>
		<author>
			<persName><forename type="first">M</forename><surname>Barbier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Gross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Aubart</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="736" to="743" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Bertoli-Avella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gillis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Morisaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Mutations in a TGFβ ligand, TGFB3, cause syndromic aortic aneurysms and dissections</title>
				<imprint>
			<date type="published" when="2015">2015</date>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="1324" to="1336" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
